Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals
AFib is a progressive condition where timely intervention is critical to disease management and, ultimately, the patient's quality of life
The system is intended for some of the tiniest patients—premature infants weighing as little as two pounds
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
StarGuide GX delivers ultra-high sensitivity and high-resolution imaging, enabling fast, confident diagnostics
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
Subscribe To Our Newsletter & Stay Updated
